The times they are a-changing – A refined proposal for finite HBV nucleos(t)ide analogue therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The times they are a-changing – A refined proposal for finite HBV nucleos(t)ide analogue therapy

Published:2021-08 Issue:2 Volume:75 Page:474-480
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Berg Thomas^ORCID,Lampertico Pietro

Publisher

Elsevier BV

Subject

Hepatology

Reference43 articles.

1. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B;Lau;N Engl J Med,2005

2. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B;Marcellin;N Engl J Med,2004

3. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;Lampertico;J Hepatol,2017

4. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B;Marcellin;N Engl J Med,2008

5. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study;Marcellin;Lancet,2013

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989;Gut;2024-09-12

2. Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B Using HBsAg Thresholds: A Meta-Analysis and Meta-Regression;Clinical Gastroenterology and Hepatology;2024-06

3. Individualizing the Approach to Stopping Nucleos(t)ide Analogs: Can We Use a Low HBsAg Threshold to Predict a High Chance of Functional Cure and Minimal Risk of Hepatic Decompensation?;American Journal of Gastroenterology;2024-04-15

4. Letter regarding “Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation”;Clinical and Molecular Hepatology;2024-04-01

5. Diagnostik und Therapie der Virushepatitis B und D im Jahr 2024;Die Innere Medizin;2024-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3